NPIPB9: A Potential Drug Target and Biomarker (G100507607)
NPIPB9: A Potential Drug Target and Biomarker
Non-protein intracellular binding protein 9 (NPIPB9) is a protein that is expressed in various cell types, including neurons, glial cells, and blood vessels. Its function is not well understood, but it is known to be involved in the regulation of intracellular signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues, and is a key regulator of many diseases, including cancer.
Recent studies have identified NPIPB9 as a potential drug target and biomarker for several diseases, including cancer. NPIPB9 has been shown to play a role in the regulation of cell proliferation, and has been shown to interact with several signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues, and is a key regulator of many diseases, including cancer.
One of the key benefits of targeting NPIPB9 is that it is a relatively small protein, which makes it easier to design and develop drugs. Additionally, its function is not well understood, which can make it easier to identify potential drug targets.
In addition to its potential as a drug target, NPIPB9 has also been identified as a potential biomarker for several diseases. For example, studies have shown that NPIPB9 is downregulated in various types of cancer, and that increasing its levels can inhibit the growth of cancer cells. This suggests that NPIPB9 may be a useful biomarker for cancer, and that targeting it may be a promising strategy for the development of new cancer treatments.
Overall, NPIPB9 is a protein that is expressed in various cell types and is involved in the regulation of intracellular signaling pathways, including the TGF-β pathway. Its function is not well understood, but it is known to play a role in the regulation of cell proliferation. As a result, it is a potential drug target and biomarker for several diseases, including cancer. Further research is needed to fully understand its role and potential as a drug.
Protein Name: Nuclear Pore Complex Interacting Protein Family Member B9
The "NPIPB9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPIPB9 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NPIPP1 | NPL | NPLOC4 | NPM1 | NPM1P13 | NPM1P21 | NPM1P22 | NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM
